Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients

BACKGROUND: Protease inhibitors (PIs) to treat hepatitis C (HCV) virus infection have been approved and others are under development. RESULTS: The aims of this study were to illustrate natural polymorphisms in the HCV protease and measure the frequency of PI resistance mutations in different HCV gen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Paolucci, Stefania, Fiorina, Loretta, Piralla, Antonio, Gulminetti, Roberto, Novati, Stefano, Barbarini, Giorgio, Sacchi, Paolo, Gatti, Marta, Dossena, Luca, Baldanti, Fausto
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493344/
https://ncbi.nlm.nih.gov/pubmed/23095680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-9-245
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia